In vivo biomarkers for targeting colorectal neoplasms

Cancer Biomarkers

Volumn 4, Issue 6, 2008, Pages 329-340

  Hsiunga, Pei Lin ^a   Wang, Thomas ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenocarcinoma; Biomarker; Colon; Endoscopy; Molecular imaging; Targeted

Indexed keywords

ANTINEOPLASTIC AGENT; APC PROTEIN; BEVACIZUMAB; CATHEPSIN B; CETUXIMAB; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PANITUMUMAB; TRANSCRIPTION FACTOR CDX2; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; COLON CARCINOGENESIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; DISEASE MARKER; DRUG EFFICACY; DRUG TARGETING; EARLY DIAGNOSIS; FLUORESCENCE ANALYSIS; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION PROFILING; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IN VIVO STUDY; MOLECULAR IMAGING; MOLECULAR PROBE; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

ANIMALIA;

EID: 58149385605     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/cbm-2008-4605     Document Type: Article

References (68)

1. American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society; 2008.
2. I. Vogelaar, M. van Ballegooijen, D. Schrag et al., How much can current interventions reduce colorectal cancer mortality in the US Mortality projections for scenarios of risk-factor modification, screening, and treatment, Cancer 107 (2006), 1624-1633.
3. M.J. O'brien, S.J. Winawer, A.G. Zauber et al., National Polyp Study Workgroup. Flat adenomas in the National Polyp Study: Is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol 2 (2004), 905-911.
4. J.C. van Rijn, J.B. Reitsma, J. Stoker, P.M. Bossuyt, S.J. van Deventer and E. Dekker, Polyp miss rate determined by tandem colonoscopy: A systematic review, Am J Gastroenterol 101 (2006), 343-350.
5. R.M. Soetikno, T. Kaltenbach, R.V. Rouse, W. Park, A. Maheshwari, T. Sato, S. Matsui and S. Friedl, Prevalence of non-polypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults, JAMA 299 (2008), 1027-1035.
6. D.P. Hurlstone, S.S. Cross, I. Adam, A.J. Shorthouse, S. Brown, D.S. Sanders and A.J. Lobo, A prospective clinico-pathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom, Am J Gastroenterol 98 (2003), 2543-2549.
7. M.J. O'brien, S.J. Winawer, A.G. Zauber, M.T. Bushey, S.S. Sternberg, L.S. Gottlieb, J.H. Bond, J.D. Waye and M. Schapiro, National Polyp Study Workgroup. Flat adenomas in the National Polyp Study: Is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol 2 (2004), 905-911.
8. E. Jaramillo, M. Watanabe, R. Befrits, E. Ponce de Leon, C. Rubio and P. Slezak, Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy, Gastrointest Endosc 44 (1996), 15-22.
9. A.C. von Roon, G. Reese, J. Teare, V. Constantinides, A.W. Darzi and P.P. Tekkis, The risk of cancer in patients with Crohn's disease, Dis Colon Rectum 50 (2007), 839-855.
10. T.A. Judge, J.D. Lewis and G.R. Lichtenstein, Colonic dysplasia and cancer in inflammatory bowel disease, Gastrointest Endosc Clin N Am 12 (2002), 495-523.
11. R. Labianca, L. Milesi, S. Mosconi, M.A. Pessi, G.D. Beretta and A. Quadri, The role of adjuvant chemotherapy in colon cancer, Surg Oncol 16 (2007), S1:S93-6.
12. D.K. Monga and M.J. O'Connell, Surgical adjuvant therapy for colorectal cancer: Current approaches and future directions, Ann Surg Oncol 13 (2006), 1021-1034.
13. B. Vogelstein, E.R. Fearon, S.R. Hamilton, S.E. Kern, A.C. Preisinger, M. Leppert, Y. Nakamura, R. White, A.M. Smits and J.L. Bos, Genetic alterations during colorectal-tumor development, N Engl J Med 319 (1988), 525-532.
14. D.C. Chung, The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis, Gastroenterology 119 (2000), 854-865.
15. K.R. Cho and B. Vogelstein, Genetic alterations in the adenoma-carcinoma sequence, Cancer 70(6S) (1992), 1727-1731.
16. T. Watanabe, T. Kobunai, E. Toda et al., Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers, Cancer Res 66 (2006), 9804-9808.
17. C. Lengauer, K.W. Kinzler and B. Vogelstein, Genetic instability in colorectal cancers, Nature 386 (1997), 623-627.
18. I. Rhee, K.W. Jair, R.W. Yen, C. Lengauer, J.G. Herman, K.W. Kinzler, B. Vogelstein, S.B. Baylin and K.E. Schuebel, CpG methylation is maintained in human cancer cells lacking DNMT1, Nature 404 (2000), 1003-1007.
19. E.J. Fox, D.T. Leahy, R. Geraghty, H.E. Mulcahy, D. Fennelly, J.M. Hyland, D.P. O'Donoghue and K. Sheahan, Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer, J Mol Diagn 8 (2006), 68-75.
20. Y. Wang, T. Jatkoe, Y. Zhang, M.G. Mutch, D. Talantov, J. Jiang, H.L. McLeod and D. Atkins, Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer, J Clin Oncol 22 (2004), 1564-1571.
21. C.P. Giacomini, S.Y. Leung, X. Chen, S.T. Yuen, Y.H. Kim, E. Bair and J.R. Pollack, A gene expression signature of genetic instability in colon cancer, Cancer Res 65 (2005), 9200-9205.
22. A. Barrier, A. Lemoine, P.Y. Boelle et al., Colon cancer prognosis prediction by gene expression profiling, Oncogene 24 (2005), 6155-6164.
23. L.K. Su, K.W. Kinzler, B. Vogelstein et al., Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene, Science 256 (1992), 668-670.
24. W. Edelmann, P.E. Cohen, B. Kneitz et al., Mammalian MutS homologue 5 is required for chromosome pairing in meiosis, Nat Genet 21 (1999), 123-127.
25. T. Van Dyke and T. Jacks, Cancer modeling in the modern era: Progress and challenges, Cell 108 (2002), 135-144.
26. J. Jonkers and A. Berns, Conditional mouse models of sporadic cancer, Nat Rev Cancer 2 (2002), 251-265.
27. J. Heyer, K. Yang, M. Lipkin, W. Edelmann and R. Kucherlapati, Mouse models for colorectal cancer, Oncogene 18 (1999), 5325-533.
28. A.K. Bhan, E. Mizoguchi, R.N. Smith and A. Mizoguchi, Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 169 (1999), 195-207.
29. G. Garcea, R.A. Sharma, A. Dennison, W.P. Steward, A. Gescher and D.P. Berry, Molecular biomarkers of colorectal carcinogenesis and their role in surveillance and early intervention, Eur J Cancer 39 (2003), 1041-1052.
30. S. Syngal, G. Clarke and P. Bandipalliam, Potential roles of genetic biomarkers in colorectal cancer chemoprevention, J Cell Biochem Suppl 34 (2000), 28-34.
31. A. Barrier, P.Y. Boelle, A. Lemoine et al., Gene expression profiling of nonneoplastic mucosa may predict clinical outcome of colon cancer patients, Dis Colon Rectum 48 (2005), 2238-2248.
32. D. Arango, P. Laiho, A. Kokko et al., Gene-expression profiling predicts recurrence in Dukes C colorectal cancer, Gastroenterology 129 (2005), 874-884.
33. Y. Takahashi, Y. Kitadai, C.D. Bucana, K.R. Cleary and L.M. Ellis, Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer, Cancer Res 55 (1995), 3964-398.
34. S.I. Ishigami, S. Arii, M. Furutani, M. Niwano, T. Harada, M. Mizumoto, A. Mori, H. Onodera and M. Imamura, Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer, Br J Cancer 78 (1998), 1379-1384.
35. T. Ono and C. Miki, Factors influencing tissue concentration of vascular endothelial growth factor in colorectal carcinoma, Am J Gastroenterol 95 (2000), 1062-1067.
36. S. Cascinu, M.P. Staccioli, G. Gasparini, P. Giordani, V. Catalano, R. Ghiselli, C. Rossi, A.M. Baldelli, F. Graziano, V. Saba, P. Muretto and G. Catalano, Expression of vascular endothelial growth factor can predict event-free survival in stage II colon cancer, Clin Cancer Res 6 (2000), 2803-2807.
37. M. Los, J.M. Roodhart and E.E. Voest, Target practice: Lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer, Oncologist 12 (2007), 443-450.
38. W.S. Chen, C.S. Lazar, M. Poenie, R.Y. Tsien, G.N. Gill and M.G. Rosenfeld, Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor, Nature 328 (1987), 820-823.
39. G. Galizia, F. Ferraraccio, E. Lieto et al., Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery, Dis Colon Rectum 47 (2004), 1904-1914.
40. M.B. Resnick, J. Routhier, T. Konkin, E. Sabo and V.E. Pricolo, Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: A tissue microarray study, Clin Cancer Res 10 (2004), 3069-3075.
41. G. Galizia, E. Lieto, F. Ferraraccio, F. De Vita, P. Castellano, M. Orditura, V. Imperatore, A. La Mura, G. La Manna, M. Pinto, G. Catalano, C. Pignatelli and F. Ciardiello, Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery, Ann Surg Oncol 13 (2006), 823-835.
42. D.J. Jonker, C.J. O'Callaghan, C.S. Karapetis et al., Cetuximab for the treatment of colorectal cancer, N Engl J Med 357 (2007), 2040-2048.
43. D. Cunningham, Y. Humblet, S. Siena et al., Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer, N Engl J Med 351 (2004), 337-345.
44. M.Wu, A. Rivkin and T. Pham, Panitumumab: Human monoclonal antibody against epidermal growth factor receptors for the treatment of metastatic colorectal cancer, Clin Ther 30 (2008), 14-30.
45. C.M. Frederiksen, S. Knudsen, S. Laurberg and T.F. Ørntoft, Classification of Dukes' B and C colorectal cancers using expression arrays, J Cancer Res Clin Oncol 129 (2003), 263-271.
46. Y. Wang, T. Jatkoe, Y. Zhang, M.G. Mutch, D. Talantov, J. Jiang, H.L. McLeod and D. Atkins, Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer, J Clin Oncol 22 (2004), 1564-1571.
47. S. Eschrich, I. Yang, G. Bloom et al., Molecular staging for survival prediction of colorectal cancer patients, J Clin Oncol 23 (2005), 3526-3535.
48. M.A. Funovics, H. Alencar, X. Montet, R. Weissleder and U. Mahmood, Simultaneous fluorescence imaging of protease expression and vascularity during murine colonoscopy for colonic lesion characterization, Gastrointest Endosc 64 (2006), 589-597.
49. H. Alencar, M.A. Funovics, J. Figueiredo, H. Sawaya, R. Weissleder and U. Mahmood, Colonic adenocarcinomas: Near-infrared microcatheter imaging of smart probes for early detection-study in mice, Radiology 244 (2007), 232-238.
50. M.A. Funovics, H. Alencar, H.S. Su, K. Khazaie, R. Weissleder and U. Mahmood, Miniaturized multichannel near infrared endoscope for mouse imaging, Mol Imaging 2 (2003), 350-357.
51. N. Uedo, H. Iishi, M. Tatsuta et al., A novel videoendoscopy system by using autofluorescence and reflectance imaging for diagnosis of esophagogastric cancers, Gastrointest Endosc 62 (2005), 521-528.
52. K. Izuishi, H. Tajiri, T. Fujii, N. Boku, A. Ohtsu, T. Ohnishi, M. Ryu, T. Kinoshita and S. Yoshida, The histological basis of detection of adenoma and cancer in the colon by autofluorescence endoscopic imaging, Endoscopy 31 (1999), 511-516.
53. N. Uedo, K. Higashino, R. Ishihara, Y. Takeuchi and H. Iishi, Digestive Endoscopy 19 (S1) (2007), S134-S138.
54. J.B. Pawley ed., Handbook of Biological Confocal Microscopy, 3rd ed., Springer Verlag, New York (2006).
55. E. Laemmel, M. Genet, G. Le Goualher, A. Perchant, J.F. Le Gargasson and E. Vicaut, Fibered confocal fluorescence microscopy (Cell-viZio) facilitates extended imaging in the field of microcirculation, A comparison with intravital microscopy, J Vasc Res 41 (2004), 400-411.
56. T.D. Wang, S. Friedland, P. Sahbaie, R. Soetikno, P.L. Hsiung, J.T. Liu, J.M. Crawford and C.H. Contag, Functional imaging of colonic mucosa with a fibered confocal microscope for real-time in vivo pathology, Clin Gastroenterol Hepatol 5 (2007), 1300-1305.
57. R.P. Baum and T.H. Brümmendorf, Radioimmunolocalization of primary and metastatic breast cancer, Q J Nucl Med 42 (1998), 33-42.
58. S. Dessureault, I. Koven, R.M. Reilly et al., Pre-operative assessment of axillary lymph node status in patients with breast adenocarcinoma using intravenous 99mtechnetium mAb-170H.82 (Tru-Scint AD), Breast Cancer Res Treat 45 (1997), 29-37.
59. D. Neri, B. Carnemolla, A. Nissim et al., Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform, Nat Biotechnol 15 (1997), 1271-1275.
60. R. Weissleder, C.H. Tung, U. Mahmood and A. Bogdanov, In vivo imaging of tumors with protease-activated near-infrared fluorescent probes, Nat Biotechnol 17 (1999), 375-378.
61. C.H. Tung, U. Mahmood, S. Bredow and R. Weissleder, In vivo imaging of proteolytic enzyme activity using a novel molecular reporter, Cancer Res 60 (2000), 4953-4958.
62. C. Bremer, C.H. Tung and R. Weissleder, In vivo molecular target assessment of matrix metalloproteinase inhibition, Nat Med 7 (2001), 743-748.
63. K. Marten, C. Bremer, K. Khazaie, M. Sameni, B. Sloane, C.H. Tung and R. Weissleder, Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice, Gastroenterology 122 (2002), 406-414.
64. P.L. Hsiung, J. Hardy, S. Friedland, R. Soetikno, C.B. Du, A.P. Wu, P. Sahbaie, J.M. Crawford, A.W. Lowe, C.H. Contag and T.D. Wang, Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy, Nat Med 14 (2008), 454-458.
65. K. Kelly, H. Alencar, M. Funovics, U. Mahmood and R. Weissleder, Detection of invasive colon cancer using a novel, targeted, library-derived fluorescent peptide, Cancer Res 64 (2004), 6247-6251.
66. J.R. Newton, K.A. Kelly, U. Mahmood, R. Weissleder and S.L. Deutscher, In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice, Neoplasia 8 (2006), 772-780.
67. T. Hinoi, A. Akyol, B.K. Theisen, D.O. Ferguson, J.K. Greenson, B.O. Williams, K.R. Cho and E.R. Fearon, Mouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic Apc Inactivation, Cancer Research, in press.
68. A. Akyol, T. Hinoi, Y. Feng, G.T. Bommer, T.M. Glaser and E.R. Fearon, Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene, Nat Methods 5 (2008), 231-233.